amiodarone has been researched along with BOOP in 24 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
" Here we describe a Caucasian woman who developed a bronchiolitis obliterans organizing pneumonia (BOOP)-like interstitial pneumonia after PTU administration for amiodarone-induced thyrotoxicosis." | 7.78 | Propylthiouracil-induced interstitial pneumonia in a Caucasian woman with amiodarone-induced thyrotoxicosis. ( Brigante, G; Diazzi, C; Rochira, V; Rossi, G, 2012) |
"Patients underwent amiodarone treatment for various reasons, most often atrial fibrillation, for more than 2 years, and those that received a cumulative dose > 100 g were enrolled." | 3.80 | The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity. ( Kang, IS; Kim, KJ; Kim, Y; Park, SH, 2014) |
" Here we describe a Caucasian woman who developed a bronchiolitis obliterans organizing pneumonia (BOOP)-like interstitial pneumonia after PTU administration for amiodarone-induced thyrotoxicosis." | 3.78 | Propylthiouracil-induced interstitial pneumonia in a Caucasian woman with amiodarone-induced thyrotoxicosis. ( Brigante, G; Diazzi, C; Rochira, V; Rossi, G, 2012) |
"Diagnosis of extrinsic allergic alveolitis is based on the association of clinical, radiological, functional, immunological criteria and bronchoalveolar lavage fluid analysis." | 2.41 | [Diffuse infiltrative lung diseases due to allergy and iatrogenic causes]. ( Dalphin, JC, 2000) |
" The most serious adverse reaction is pulmonary toxicity." | 2.40 | [Amiodarone-induced pulmonary toxicity]. ( Berg, M; Heisel, A; Schieffer, H; Stopp, M; Ukena, D, 1997) |
"We report a case of cryptogenic organizing pneumonia secondary to amiodarone treatment, its clinical course with significant improvement of clinical symptoms within a few days after discontinuation of amiodarone treatment and administration of corticosteroids." | 1.36 | Cryptogenic organizing pneumonia due to amiodarone: long-term follow-up after corticosteroid treatment. ( Kaliman, JF; Schima, W; Schindler, K, 2010) |
"Pneumonitis is a serious adverse effect of amiodarone therapy, which is related to the average daily dose." | 1.29 | Amiodarone pneumonitis: no safe dose. ( Polkey, MI; Rees, PJ; Wilson, PO, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (29.17) | 18.2507 |
2000's | 11 (45.83) | 29.6817 |
2010's | 4 (16.67) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Coulier, B | 1 |
Colin, GC | 1 |
Beniuga, G | 1 |
Zizzo, G | 1 |
Caruso, S | 1 |
Ricchiuti, E | 1 |
Turato, R | 1 |
Stefani, I | 1 |
Mazzone, A | 1 |
Kang, IS | 1 |
Kim, KJ | 1 |
Kim, Y | 1 |
Park, SH | 1 |
Piciucchi, S | 1 |
Dubini, A | 1 |
Tomassetti, S | 1 |
Casoni, G | 1 |
Ravaglia, C | 1 |
Poletti, V | 1 |
Stiefelhagen, P | 1 |
Heisel, A | 1 |
Berg, M | 1 |
Stopp, M | 1 |
Ukena, D | 1 |
Schieffer, H | 1 |
Miyaki, J | 1 |
Souma, S | 1 |
Narumiya, Y | 1 |
Chiba, S | 1 |
Fernández-Ruiz, M | 1 |
Guerra-Vales, JM | 1 |
Villena-Garrido, V | 1 |
Schindler, K | 1 |
Schima, W | 1 |
Kaliman, JF | 1 |
Diazzi, C | 1 |
Brigante, G | 1 |
Rossi, G | 1 |
Rochira, V | 1 |
Ott, MC | 1 |
Khoor, A | 1 |
Leventhal, JP | 1 |
Paterick, TE | 1 |
Burger, CD | 1 |
Malhotra, A | 1 |
Muse, VV | 1 |
Mark, EJ | 1 |
Ponce, MA | 1 |
Pérez-Peñate, G | 1 |
Cabrera, P | 1 |
Juliá, G | 1 |
Epler, GR | 1 |
Omeroglu, G | 1 |
Kalugina, Y | 1 |
Ersahin, C | 1 |
Wojcik, EM | 1 |
Sveinsson, OA | 1 |
Isaksson, HJ | 1 |
Guethmundsson, G | 1 |
Polkey, MI | 1 |
Wilson, PO | 1 |
Rees, PJ | 1 |
Valle, JM | 1 |
Alvarez, D | 1 |
Antúnez, J | 1 |
Valdés, L | 1 |
Oren, S | 1 |
Turkot, S | 1 |
Golzman, B | 1 |
London, D | 1 |
Ben-Dor, D | 1 |
Weiler, Z | 1 |
Jessurun, GA | 1 |
Hoogenberg, K | 1 |
Crijns, HJ | 1 |
Conte, SC | 1 |
Pagan, V | 1 |
Murer, B | 1 |
Antón Aranda, E | 1 |
Alkiza Basañez, R | 1 |
Laplaza Jiménez, Y | 1 |
Pía Iglesias, G | 1 |
Garrido Sanjuán, JA | 1 |
Fernández Fernández, F | 1 |
Sesma Sánchez, P | 1 |
Dalphin, JC | 1 |
3 reviews available for amiodarone and BOOP
Article | Year |
---|---|
[Amiodarone-induced pulmonary toxicity].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bronchial Spasm; Controlled Clinical Trials as Topic; Cryptogeni | 1997 |
Drug-induced bronchiolitis obliterans organizing pneumonia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Antineoplastic Agents; Cryptogen | 2004 |
[Diffuse infiltrative lung diseases due to allergy and iatrogenic causes].
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Cr | 2000 |
21 other studies available for amiodarone and BOOP
Article | Year |
---|---|
Amiodarone-induced cryptogenic organizing pneumonia (COP).
Topics: Amiodarone; Biopsy; Cryptogenic Organizing Pneumonia; Humans; Lung | 2020 |
Amiodarone-induced organizing pneumonia mimicking COVID-19: a case report.
Topics: Aged; Amiodarone; COVID-19; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Humans; Male; | 2021 |
The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Sectional Studies; Cryptogenic | 2014 |
A case of amiodarone-induced acute fibrinous and organizing pneumonia mimicking mesothelioma.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; | 2015 |
[From where come the spot-form shadows in thoracic radiography? Corticoids make them disappear].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation | 2008 |
[Case of unilateral organizing pneumonia induced by amiodarone pulmonary toxicity].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Humans; Male | 2009 |
[Bronchiolitis obliterans with organized pneumonia secondary to amiodarone: presentation of two cases with different therapeutic approach].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Female; Hum | 2009 |
Cryptogenic organizing pneumonia due to amiodarone: long-term follow-up after corticosteroid treatment.
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; | 2010 |
Propylthiouracil-induced interstitial pneumonia in a Caucasian woman with amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Cryptogenic Organ | 2012 |
Pulmonary toxicity in patients receiving low-dose amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Biopsy; Cryptogenic Organizing Pneumonia; Dose-Response Relatio | 2003 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2003. An 82-year-old man with dyspnea and pulmonary abnormalities.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Bundle | 2003 |
[Bronchiolitis obliterans organizing pneumonia and amiodarone: spontaneous resolution].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Humans; Male; Remission, | 2004 |
Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biopsy, Fine-Needle; Chronic Disease; Cryptogenic Organizi | 2006 |
[Organising pneumonia in connection with Amiodarone treatment. Case reports and review].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Female; Humans; Male; Me | 2006 |
Amiodarone pneumonitis: no safe dose.
Topics: Aged; Amiodarone; Contraindications; Cryptogenic Organizing Pneumonia; Humans; Male | 1995 |
Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology.
Topics: Amiodarone; Arrhythmias, Cardiac; Biopsy; Cryptogenic Organizing Pneumonia; Female; Humans; Lung; Mi | 1995 |
Amiodarone-induced bronchiolitis obliterans organizing pneumonia (BOOP).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Fatal Outcome; Humans; M | 1996 |
Bronchiolitis obliterans organizing pneumonia during low-dose amiodarone therapy.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Femal | 1997 |
Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: clinical, radiological and histological pattern.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Humans; Lung; Male; Radi | 1997 |
Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Biopsy, Nee | 1998 |
[Bronchiolitis obliterans with focal organizing pneumonia and amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cryptogenic Organizing Pneumonia; Female; Humans; Middle Aged | 2000 |